Literature DB >> 7502275

Design and synthesis of thrombin substrates with modified kinetic parameters.

D T Rijkers1, S J Wielders, G I Tesser, H C Hemker.   

Abstract

For the continuous registration of thrombin formation in plasma (1), selective thrombin substrates are required, that show moderate binding affinities (high Km) and low turnover numbers (low kcat). Previously we have used SQ68 (CH3O-CO-CH2-CO-Aib-Arg-pNA) for this purpose. In order to find more substrates suitable for this application, we synthesized a series of 25 peptide p-nitroanilides. As lead structures SQ68 and S2238 (H-D-Phe-Pip-Arg-pNA) were used. By introduction of specific structure modifications we tried to alter the kinetic data in the required direction. The modifications were designed on basis of existing knowledge on the structure of the thrombin active-site and its surroundings. We indeed obtained a number of substrates with the kinetic constants in the desired range.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7502275     DOI: 10.1016/0049-3848(95)00139-i

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  3 in total

1.  Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis.

Authors:  Kevin Y Lin; Gabriel A Kwong; Andrew D Warren; David K Wood; Sangeeta N Bhatia
Journal:  ACS Nano       Date:  2013-09-12       Impact factor: 15.881

2.  The role of DNA nanostructures in the catalytic properties of an allosterically regulated protease.

Authors:  Richard Kosinski; Joel Mieres Perez; Elisa-C Schöneweiß; Yasser B Ruiz-Blanco; Irene Ponzo; Kenny Bravo-Rodriguez; Michael Erkelenz; Sebastian Schlücker; Guido Uhlenbrock; Elsa Sanchez-Garcia; Barbara Saccà
Journal:  Sci Adv       Date:  2022-01-05       Impact factor: 14.136

3.  Bioengineering of improved biomaterials coatings for extracorporeal circulation requires extended observation of blood-biomaterial interaction under flow.

Authors:  Kris N J Stevens; Yvette B J Aldenhoff; Frederik H van der Veen; Jos G Maessen; Leo H Koole
Journal:  J Biomed Biotechnol       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.